Wang W - Search Results

1

Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study.

Wang W, Qian HJ, Xin L, Zhang MQ, Lu DY, Jin JM, Liu GY, Jia JY, Zheng HC, Yu C, Wang YP, Zhu F, Liu Y. Wang W, et al. Among authors: wang yp. Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):593-599. doi: 10.1007/s13318-016-0370-1. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27550655 Clinical Trial.

2

Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.

Liu YM, Pu HH, Liu GY, Jia JY, Weng LP, Xu RJ, Li GX, Wang W, Zhang MQ, Lu C, Yu C. Liu YM, et al. Among authors: wang w. Clin Ther. 2010 Jul;32(7):1396-407. doi: 10.1016/j.clinthera.2010.07.004. Clin Ther. 2010. PMID: 20678686 Clinical Trial.

3

Relative bioavailability of generic and branded acetylcysteine effervescent tablets: A single-dose, open-label, randomized-sequence, two-period crossover study in fasting healthy Chinese male volunteers.

Liu YM, Liu Y, Lu C, Jia JY, Liu GY, Weng LP, Wang JY, Li GX, Wang W, Li SJ, Yu C. Liu YM, et al. Among authors: wang w, wang jy. Clin Ther. 2010 Nov;32(12):2097-105. doi: 10.1016/j.clinthera.2010.11.001. Clin Ther. 2010. PMID: 21118745 Clinical Trial.

4

Bioequivalence and pharmacokinetic evaluation of two formulations of risperidone 2 mg : an open-label, single-dose, fasting, randomized-sequence, two-way crossover study in healthy male Chinese volunteers.

Liu Y, Zhang MQ, Jia JY, Liu YM, Liu GY, Li SJ, Wang W, Weng LP, Yu C. Liu Y, et al. Among authors: wang w. Drugs R D. 2013 Mar;13(1):29-36. doi: 10.1007/s40268-012-0002-4. Drugs R D. 2013. PMID: 23322527 Free PMC article. Clinical Trial.

5

Pharmacokinetics and tolerability of Tenofovir disoproxil fumarate 300 mg once daily: an open-label, single- and multiple-dose study in healthy Chinese subjects.

Hu CY, Liu YM, Liu Y, Chen Q, Wang W, Wu K, Dong J, Li J, Jia JY, Lu C, Sun SX, Yu C, Li X. Hu CY, et al. Among authors: wang w. Clin Ther. 2013 Dec;35(12):1884-9. doi: 10.1016/j.clinthera.2013.09.020. Epub 2013 Oct 19. Clin Ther. 2013. PMID: 24148552 Clinical Trial.

6

Determination of the novel antiarrhythmic drug sulcardine sulfate in human plasma by liquid chromatography tandem mass spectrometry and its application in a clinical pharmacokinetic study.

Jia J, Liu G, Zhang M, Lu Y, Lu C, Liu Y, Zheng H, Wang W, Gui Y, Yu C, Li S, Wang Y. Jia J, et al. Among authors: wang w, wang y. Biomed Chromatogr. 2016 Aug;30(8):1291-6. doi: 10.1002/bmc.3681. Epub 2016 Feb 8. Biomed Chromatogr. 2016. PMID: 26715470

7

Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open-label, single-dose, randomized study in healthy Chinese subjects.

Chen Q, Qian HJ, Wang W, Zhang MQ, Lu DY, Lu C, Jin JM, Hu CY, Liu GY, Jia JY, Zheng HC, Li XN, Yu C, Wang YP, Liu Y. Chen Q, et al. Among authors: wang w, wang yp. Fundam Clin Pharmacol. 2017 Feb;31(1):120-125. doi: 10.1111/fcp.12242. Epub 2016 Oct 5. Fundam Clin Pharmacol. 2017. PMID: 27599871 Clinical Trial.

8

Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study.

Chen Q, Hu C, Liu Y, Liu Y, Wang W, Zheng H, Rong L, Jia J, Sun S, Yu C, Liu YM. Chen Q, et al. Among authors: wang w. PLoS One. 2017 May 11;12(5):e0177425. doi: 10.1371/journal.pone.0177425. eCollection 2017. PLoS One. 2017. PMID: 28493932 Free PMC article. Clinical Trial.

9

Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects.

Qian H, Fan S, Li K, Sai Y, Su W, Chen Q, Liu Y, Li T, Wang W, Jia J, Yu C, Liu Y. Qian H, et al. Among authors: wang w. Clin Ther. 2019 Aug;41(8):1537-1544. doi: 10.1016/j.clinthera.2019.05.014. Epub 2019 Jul 1. Clin Ther. 2019. PMID: 31272709 Clinical Trial.

10

Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects.

Qian H, Wu X, Chen Q, Li T, Wang W, Jia J, Yu C, Li K, Sai Y, Su W, Liu Y. Qian H, et al. Among authors: wang w. Clin Ther. 2020 Sep;42(9):1778-1786. doi: 10.1016/j.clinthera.2020.07.010. Epub 2020 Aug 13. Clin Ther. 2020. PMID: 32800383 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88,413 results

Search Page

Filters